Global Mitomycin C Market Study 2015-2025, by Segment (2 Mg, 10 Mg, 40 Mg), by Market (Cancer Treatment, Ophthalmic Use10 Mg, Others), by Company (Kyowa-kirin, Intas Pharmaceuticals, Teva)
ReportPage
Report ID
16197
Published Date
26-Sep
No of Report Page
82
Report Category
Pharmaceuticals and Healthcare
Editor's Rating
US $3,600.00
US $3,600.00
US $1,800.00

  • Report Details 
    Snapshot
    
Mitomycin C is an antibiotic which acts as a double-stranded DNA alkylating agent. It covalently crosslinks DNA, inhibiting DNA synthesis and cell proliferation It acts by way of reductive activation either through low pH or NAD(P)H:quinone oxidoreductase (DT-diaphorase) or NADH cytochrome c reductase (Mao et al.; Cummings et al.).
    
The global Mitomycin C market will reach xxx Million USD
    More...
  • Table Of Content 
    Table of Content
    
1 Industry Overview
    
    1.1 Mitomycin C Industry
    
        1.1.1 Overview
    
        1.1.2 Products of Major Companies
    
    1.2 Market Segment
    
        1.2.1 Industry Chain
    
        1.2.2 Consumer Distribution
    
    1.3 Price & Cost Overview
    
2 Mitomycin C Market by Type
    
    2.1 By Type
    
       2.1.1 2 Mg
    
       2.1.2 10 Mg
    
       2.1.3 40 Mg
    
       2.1.4 Others
    
    2.2 Market Size by Type
    More...
  • Inquiry Before Buying
    Inquiry Before Buying -
  • Request Sample
    Request For Sample
portalmarketdeskus
 
Office No 8, 3rd Floor, Aston Plaza, Katraj - Ambegaon Road, Ambegaon BK, Pune, Maharashtra, India. Pin- 411046
Navigation : -
Connect with Us : -
Secured Payment Options : -